News
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.
Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...
Novo Nordisk's drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC's ...
McDonald’s faces falling visits and shrinking demand as GLP-1 drugs and price fatigue reshape consumer habits.
Wegovy can help people with excess weight and obesity lose weight and improve their health. And you don’t need to drive to a ...
Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the Danish ...
Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...
Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...
New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...
Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results